$VCYT Income Statement | Understand Stock

$VCYT

$48.20 +$0.27 (0.56%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Revenue
Testing revenue
Product revenue
Biopharmaceutical and other revenue
Total revenue
Cost of revenue:
Cost of revenue
Testing revenue
Product revenue
Biopharmaceutical and other revenue
Intangible asset amortization - cost of revenue
Total cost of revenue
Gross profit
Operating expenses:
Research and development
Selling and marketing
General and administrative
Impairment of assets
Intangible asset amortization
Intangible asset amortization - operating expenses
Total operating expenses
Income (loss) from operations
Other income, net
Income (loss) before income taxes
Income tax provision (benefit)
Net income (loss)
Earnings (loss) per share:
Basic (in USD per share)
Diluted (in USD per share)
Shares used to compute earnings (loss) per common share:
Basic (in shares)
Diluted (in shares)

Comments